Harmik J. Soukiasian M.D., director of the Division of Thoracic Surgery

Harmik Soukiasian M.D.

Director, Division of Thoracic Surgery

About Harmik Soukiasian

Dr. Harmik Soukiasian is the director of the Division of Thoracic Surgery and a key member of the Mesothelioma Program at Cedars-Sinai Health System in Los Angeles.

Get in touch

Accolades

Team Leader icon

Team Leader

Pleural and Lung Cancer icon

Pleural Mesothelioma

VAT Surgery icon

Video-Assisted Thoracoscopic Surgery

Research Excellence icon

Excellence in Research

At Cedars-Sinai, Soukiasian has affiliations with the Women’s Guild Lung Institute, the Esophageal Center and the Samuel Oschin Cancer Center.

He has emerged as one of the surgical leaders at Cedars-Sinai since arriving more than a decade ago.

Soukiasian graduated from the nearby Keck School of Medicine at the University of Southern California in 1998 and completed fellowships at UCLA, Cedars-Sinai and the University of Pittsburgh Medical Center.

Involved with Groundbreaking Research

In 2018, he presented a groundbreaking study at the American Association for Thoracic Surgery annual meeting that documented the benefits of early intervention for non-small cell lung cancers.

He was part of the first surgical team on the West Coast to use a special implanted device to stimulate respiratory muscles in the chest for patients suffering from Lou Gehrig’s disease.

The surgery came just days after approval from the Food and Drug Association.

His clinical interests include photodynamic therapy, video-assisted thoracoscopic surgery, radiofrequency ablation, esophageal cancers, lung cancers, lung volume reduction surgery and pleural mesothelioma.

Lead Role in Mesothelioma Program

He is the lead surgeon in Cedars-Sinai’s Mesothelioma Program, which includes disease-specific expertise in medical oncology, radiation oncology, hematology, pulmonary medicine and research.

The Mesotheloma Program offers services on everything from early-detection tests to novel treatments. It includes clinical trials and a tumor board that meets to develop a personalized treatment plan for every patient.

The program also is part of the Supportive Care Medicine Program at Cedars-Sinai that assists patients with post-surgery rehabilitation, spiritual care, clinical nutrition, and psychiatry services, along with palliative care when appropriate.

Soukiasian also has an extensive research background.

He has written about lung cancer in nonsmoking women and the specific molecular and pathological features that have led to improved treatment.

Disclaimer: Dr. Harmik Soukiasian has no professional affiliation with Asbestos.com.

  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?


Tim Povtak, Senior Content Writer at Asbestos.com

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers. Read More

Last Modified August 1, 2018
Sources
  1. Ingram, I. (2018, May 1). Each Week of Surgical Delay May Increase NSCLC Upstaging.
    Retrieved from: https://www.medpagetoday.com/hematologyoncology/lungcancer/72642
  2. Cedars-Sinai. (n.d.). Harmik J. Soukiasian, MD.
    Retrieved from: http://bio.csmc.edu/view/3908/Harmik-J-Soukiasian.aspx
  3. Cedars Sinai. (n.d.). Mesothelioma Program. Retrieved from: https://www.cedars-sinai.org/programs/cancer/we-treat/mesothelioma.htm
Harmik Soukiasian
Get Help Contacting Harmik Soukiasian

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get Your Free Mesothelioma Guide Chat live with a patient advocate now loading spinner